Applied Molecular Transport to Host Virtual Research & Development Day on October 15, 2021
12 October 2021 - 7:01AM
Applied Molecular Transport Inc. (Nasdaq: AMTI) (AMT), a
clinical-stage biopharmaceutical company, today announced that the
company will host a virtual Research & Development Day on
Friday, October 15, 2021, from 11:00 a.m. – 1:00 p.m. ET. The
webcast event will focus on a review of the company’s novel oral
biologics technology platform, clinical programs and research
activities.
The company’s management team will be joined by
IBD and rheumatology key opinion leaders:
- Brian G. Feagan, M.D., FRCPC,
professor of medicine, Departments of Medicine, Division of
Gastroenterology, Epidemiology and Biostatistics at Western
University Canada
- Peter E. Lipsky, M.D., rheumatology
specialist and former scientific director and chief of the
Autoimmunity Branch at NIAMS, NIH
Registration for the event as well as a live and
archived webcast of the R&D Day will be available on the Events
page of the Applied Molecular Transport website at
https://ir.appliedmt.com/news-events/events.
About Applied Molecular Transport
Inc.Applied Molecular Transport Inc. is a clinical-stage
biopharmaceutical company leveraging its proprietary technology
platform to design and develop a pipeline of novel oral biologic
product candidates to treat autoimmune, inflammatory, metabolic,
and other diseases. AMT’s proprietary technology platform allows it
to exploit existing natural cellular trafficking pathways to
facilitate the active transport of diverse therapeutic modalities
across the intestinal epithelial (IE) barrier. Active transport is
an efficient mechanism that uses the cell’s own machinery to
transport materials across the IE barrier. AMT believes that its
ability to exploit this mechanism is a key differentiator of its
approach. AMT is developing additional oral biologic product
candidates in patient-friendly oral forms that are designed to
either target local gastrointestinal tissue or enter systemic
circulation to precisely address the relevant biology of a
disease.
AMT’s headquarters, internal GMP manufacturing
and lab facilities are located in South San Francisco, CA. For
additional information on AMT, please visit www.appliedmt.com.
Investor Relations
Contact:Andrew ChangHead, Investor Relations &
Corporate Communicationsachang@appliedmt.com
Media Contacts:Alexandra
SantosWheelhouse Life Science Advisorsasantos@wheelhouselsa.com
Aljanae ReynoldsWheelhouse Life Science
Advisorsareynolds@wheelhouselsa.com
Applied Molecular Transp... (NASDAQ:AMTI)
Historical Stock Chart
From Mar 2024 to Apr 2024
Applied Molecular Transp... (NASDAQ:AMTI)
Historical Stock Chart
From Apr 2023 to Apr 2024